Universal off-the-shelf combination immunotherapy using oncolytic viruses to redirect T cell engagers to target solid tumors

ABSTRACT:

SUBMITTER: Park A 

PROVIDER: S-EPMC12352182 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature